SCHEMBL10001425

SCHEMBL10001425

CC1(C)c2ccccc2-c2ccc(-n3c4ccc(-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)cc4c4cc5c(cc43)C(C)(C)c3ccccc3-5)cc21

nearest known ligand 0.40

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ HDAC4 P56524 1/20 0.33
▸ PTGER4 P35408 1/20 0.32
▸ PGR P06401 1/20 0.32
▸ TSPO P30536 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10001508 1.00 KDM4E (0.40) KDM4EATML3MBTL1HDAC4PTGER4
SCHEMBL14960723 0.99 KDM4E (0.39) KDM4EATML3MBTL1HDAC4PTGER4
SCHEMBL14822256 0.97 KDM4E (0.41) KDM4EATML3MBTL1HDAC4PTGER4
SCHEMBL14822265 0.97 KDM4E (0.41) KDM4EATML3MBTL1HDAC4PTGER4
SCHEMBL14960776 0.97 KDM4E (0.41) KDM4EATML3MBTL1HDAC4PTGER4
SCHEMBL16744958 0.97 KDM4E (0.43) KDM4EATML3MBTL1HDAC4PTGER4
SCHEMBL15946316 0.97 KDM4E (0.33) KDM4EATML3MBTL1HDAC4TSPO
SCHEMBL19195990 0.96 KDM4E (0.40) KDM4EATML3MBTL1HDAC4PTGER4
SCHEMBL15946285 0.96 KDM4E (0.40) KDM4EATML3MBTL1HDAC4PTGER4
SCHEMBL14849836 0.95 KDM4E (0.42) KDM4EATML3MBTL1HDAC4PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021037401-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-03-04 — — WO disclosed
EP-3222613-A1 COMPOUND HAVING INDENOCARBAZOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE Hodogaya Chemical Co., Ltd. (JP) 2017-09-27 — — EP disclosed
EP-2599773-B1 COMPOUND HAVING INDENOCARBAZOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT HODOGAYA CHEMICAL CO LTD (JP) 2017-03-29 — — EP disclosed
US-9196837-B2 Compound having indenocarbazole ring structure, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2015-11-24 — — US disclosed
US-9196837-B2 Compound having indenocarbazole ring structure, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2015-11-24 — — US disclosed
WO-2014204464-A1 PHOSPHORESCENT ORGANIC LIGHT EMITTING DEVICES HAVING A HOLE-TRANSPORTING HOST IN THE EMISSIVE REGION UNIVERSAL DISPLAY CORPORATION (US) 2014-12-24 — — WO disclosed
EP-2599773-A1 COMPOUND HAVING INDENOCARBAZOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT Hodogaya Chemical Co., Ltd. (JP) 2013-06-05 — — EP disclosed
US-20130126856-A1 COMPOUND HAVING INDENOCARBAZOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2013-05-23 — — US disclosed
US-20130126856-A1 COMPOUND HAVING INDENOCARBAZOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2013-05-23 — — US disclosed
WO-2012014500-A1 COMPOUND HAVING INDENOCARBAZOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT 保土谷化学工業株式会社 (JP) 2012-02-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130126856-A1 COMPOUND HAVING INDENOCARBAZOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE SLCO2B1, SLCO1B1, SLCO2A1 KDM4E 1716/4885ATM 4800/4885L3MBTL1 2253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback